tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA

Verona Pharma (VRNA) Financial Statements

481 Followers

Verona Pharma Financial Overview

Verona Pharma's market cap is currently ―. The company's EPS TTM is $-0.689; its P/E ratio is -23.93; Verona Pharma is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 458.00K
Gross Profit----$ 112.00K
EBIT$ -13.56M$ -14.24M$ -7.76M$ -16.28M$ -19.68M
EBITDA$ -13.32M$ -14.04M$ -7.55M$ -16.03M$ -19.50M
Net Income Common Stockholders$ -14.13M$ -8.77M$ -8.81M$ -16.74M$ -10.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 271.77M$ 257.37M$ 270.73M$ 291.42M$ 227.83M
Total Assets$ 308.12M$ 292.47M$ 303.93M$ 323.13M$ 259.47M
Total Debt$ 51.33M$ 20.30M$ 20.43M$ 20.52M$ 10.65M
Net Debt$ -220.44M$ -237.06M$ -250.29M$ -270.89M$ -217.18M
Total Liabilities$ 58.84M$ 28.94M$ 30.84M$ 46.40M$ 29.00M
Stockholders Equity$ 249.28M$ 263.53M$ 273.14M$ 276.76M$ 230.47M
Cash Flow-
Free Cash Flow$ -10.40M$ -12.73M$ -21.31M$ -5.78M$ -7.74M
Operating Cash Flow$ -10.40M$ -12.73M$ -21.31M$ -5.78M$ -7.74M
Investing Cash Flow-----
Financing Cash Flow$ 24.01M$ 48.00K$ 124.00K$ 68.69M$ 2.61M
Currency in USD

Verona Pharma Earnings and Revenue History

Verona Pharma Debt to Assets

Verona Pharma Cash Flow

Verona Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis